Solidifying MRD Testing as a Decision-Making Tool in Standard Clinical Practice – A Clinician’s Perspective
Time: 2:15 pm
day: Day Two
• How will progress compare between solid Vs liquid tumors?
• How do analytical parameters of precision medicine testing influence and augment clinical utility and outcome?
• Differentiators between US & EU locations for supporting streamlined drug and companion diagnostic regulatory strategy execution and submissions